MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.51
-0.01 (-2.59%)
As of Sep 28, 10:45 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,937.9% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.51
Current
$0.51
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
1,150.7%
Low target
Base Case
$10.33
+1,937.9%
Avg target
Bull Case
$12.82
+2,429.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.85
-72.6% from high
52-Week Low
$0.47
+8.7% from low
Target vs 52W High
$10.33
+458.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%